AKT1 and glioma: To further determine whether ABCE1 down-regulation inhibited TMZ resistance of glioma cells via inactivation of the PI3K/Akt/NF-κB pathway, LY294002 (Akt inhibitor) and PDTC (NF-κB inhibitor) were respectively used after TMZ treatment.